Category Archives: News

Learn How to Pass a Test for Drugs Fast: Passing a Urine Drug Test and Other Information

There are many people trying to find their place in this world. We might think of it as an existential crisis, and everyone gets to experience it. Finding meaning in whatever we do is an inherently human thing. It might be difficult or even impossible, but we try anyway. There are many questions that we… Read More: Learn How to Pass a Test for Drugs Fast: Passing… »

Can Hims' New Premature Ejaculation Spray Make Sex Last Longer?

Getty ImagesBenjamin Di Nunzio / EyeEm For many men, how long they last during sex comes wrapped in anxiety and according to some studies, anywhere from 4-40% of men deal with some sort of premature ejaculation. (Credit that huge range to the fact that “premature ejaculation” is not a well-defined affliction. More on that below.)… Read More: Can Hims' New Premature Ejaculation Spray Make Sex Last Longer? »

Self-Care getaways and retreats to help you relax, relate, release

(Photo: Fotolia/Olly) Self-care. It’s an act we crave and a hashtag we rediscover each time our bodies tell us it’s time for a little break. As the saying goes, you can’t fill other people’s wells when yours is empty. If you’ve put off giving your body and mind time to recharge, what better opportunity than… Read More: Self-Care getaways and retreats to help you relax, relate, release »

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More: Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for… »